Cellromax Science Co., Ltd. (KOSDAQ:471820)
4,920.00
+60.00 (1.23%)
At close: Jan 23, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 54.78 billion as of January 23, 2026. Its market cap has decreased by -13.67% in one year.
Market Cap
54.78B
Enterprise Value
49.58B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,920.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 54.78B, a decrease of -40.89%. That is a compound annual growth rate of -37.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 54.78B | -24.31% |
| Dec 30, 2025 | 72.38B | 26.47% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Black Yak I&C Co.,Ltd | 86.02B |
| ALT Co., Ltd. | 83.53B |
| Laseroptek | 76.17B |
| Korea No.14 Special Purpose Acquisition | 66.79B |
| JNB Co., Ltd. | 63.47B |
| Catis. | 46.59B |
| Mirae Asset Vision Special Purpose Acquisition 2 Company | 43.29B |
| ADforus | 39.63B |